A new immunotherapy approach presented by scientists has sparked widespread discussion in the field of cancer treatment. Researchers claim this experimental method completely destroys tumors and metastases, presenting the approach as a potential revolution in medical science.
The editorial reports that according to the disclosed information, the new therapy alters the tumor's microenvironment, turning it into an "enemy" for cancer and metastases, and an "ally" for the body. It is stated that this environment creates conditions for the immune system to act more effectively against cancer cells.
The information emphasizes that the new CAR T-cell therapy creates a "Trojan horse" mechanism for immune defense. According to claims, "spy" cells begin to destroy the tumor immediately after penetrating its interior and completely eradicate it from the body. Scientists state that this approach is effective against any type of cancer, including the most dangerous forms such as sarcoma, colorectal cancer, and pancreatic cancer.
Researchers also note that the experimental treatment showed a 100% success rate in animal trials, and clinical trials on humans are planned to begin soon. However, experts remind that at this stage, the results are based solely on preliminary scientific observations, and the safety and efficacy in humans must be confirmed through clinical trials.